AI in medical communications

Integration of AI in Medical Communications: A Roadmap

AI in medical communications: Why it matters now Artificial intelligence (AI) is rapidly reshaping medical communications (MedComms), driven by the necessity for personalization, efficiency, and speed in content delivery. As pharmaceutical companies face mounting competition, the demand for innovative communication strategies to communicate complex data and information, as early as the critical pre-launch phase, is…...
Read More

Top Stories

Nelson memo

The Nelson Memo: Igniting a Global Open Data

The landscape of scientific research is undergoing a seismic...
Rare diseases

Rare Diseases – An Evolving Medical

A disease is considered rare when it affects fewer than 1 in...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Why the Healthcare Industry MUST Care About the Caregiver

Why the Healthcare Industry MUST Care About the Caregiver

Caregivers are vital in the treatment of a patient, whether at home or in a...
Data-driven QMS Alignment-Feature image for the 30-sec video reel - AMDS

Medical Device Manufacturing: Risk-Based QMS Alignment for EU MDR

The latest EU-MDR guidelines are a step in the right direction, moving from a focus...
Digital Medical Communications Teams in Pharma

The Evolution of Medical Communications: How to Get the Most Out of Standard Response Documents

Better patient awareness has led to a rapid increase in the number of MI requests...
Pharma listening to patients

Ways Pharma Showed Patients How They Matter

Patient centricity is transforming the life sciences industry today. Here are outstanding examples of how...

From Transactional to Transformational: Bringing Patient Centricity to the Next Level

The pharma industry’s focus is shifting from the transactional approach to a transformational approach by...
Patient centricity in pharma

The Evolving State of Patient Centricity in the Pharmaceutical Industry

Patient centricity has been a point of discussion in pharma for years. Learn what patient...

Learn more ABOUT our company.